Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Annual and Interim Reports
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Annual and Interim Reports
Apr 23, 2024
2023 Annual Report to shareholders
Feb 29, 2024
Appendix 4E and 2023 full year accounts
Aug 28, 2023
Half Yearly Report and Accounts
Apr 27, 2023
2022 Annual Report to shareholders
Aug 24, 2022
Half Yearly Report and Accounts
Apr 27, 2022
Annual Report to shareholders
Feb 24, 2022
Preliminary Final Report and 2021 Full Year Accounts
Aug 25, 2021
Half Yearly Report and Accounts
Apr 27, 2021
Annual Report to shareholders
Feb 24, 2021
Preliminary Final Report and 2020 full year accounts
Aug 26, 2020
Half Yearly Report and Accounts
Apr 29, 2020
Annual Report 2019
Feb 26, 2020
Appendix 4E and 2019 full year accounts
Aug 28, 2019
Half Yearly Report and Accounts
Apr 26, 2019
Annual Report to shareholders
Feb 27, 2019
Preliminary Final Report and statutory accounts
Aug 31, 2018
Half Yearly Report and Accounts
May 08, 2018
Annual Report to shareholders
Mar 29, 2018
Full Year Statutory Accounts
Feb 28, 2018
Preliminary Final Report
Aug 24, 2017
Half Yearly Report and Accounts
Apr 28, 2017
Annual Report to shareholders
Mar 30, 2017
Full Year Statutory Accounts
Feb 23, 2017
Preliminary Final Report
Aug 30, 2016
Half Yearly Report and Accounts
Apr 18, 2016
Annual Report to shareholders
Aug 25, 2015
Half Yearly Report and Accounts 30 June 2015
Mar 25, 2015
Annual Report to shareholders
Feb 25, 2015
Preliminary Final Report and 2014 full year accounts
Aug 28, 2014
Half Yearly Report and Accounts
Mar 27, 2014
Annual Report to shareholders
Feb 27, 2014
Preliminary Final Report and audited Financial Statements
Aug 29, 2013
Half Yearly Report and Accounts
Mar 28, 2013
Annual Report to shareholders
Feb 28, 2013
Preliminary Final Report
Aug 30, 2012
Half Yearly Report and Accounts
Mar 30, 2012
Neuren 2011 Annual Report
Feb 29, 2012
Neuren 2011 Preliminary Final Report
Aug 30, 2011
Half Yearly Report and Accounts
Mar 31, 2011
Annual Report to shareholders
Feb 28, 2011
Preliminary Final Report
Aug 26, 2010
Half Yearly Report and Accounts
Mar 30, 2010
Annual Report to shareholders
Feb 26, 2010
Preliminary Final Report
Aug 31, 2009
Half Year Report and Accounts
Mar 31, 2009
Annual Report to shareholders
Feb 27, 2009
Preliminary Final Report
Dec 24, 2008
Neuren Announces Glypromate Trial Preliminary Results
Aug 29, 2008
Half Yearly Report and Accounts
Mar 31, 2008
Annual Report to shareholders
Feb 29, 2008
Appendix 4E Preliminary Final Report
Aug 31, 2007
Half Yearly Report and Accounts
Mar 29, 2007
Annual Report
Mar 16, 2007
Preliminary Final Report